APIM Therapeutics
Dr. Stener Kvinnsland has more than 30 years of experience in oncology. He is currently Chairman of the Board at the Trond Mohn Foundation, the Oslo University Hospital and Helse Stavanger Hf. Among Dr. Kvinnsland’s previous roles, he was Chief Executive Officer of the Bergen Hospital Trust (Helse Bergen), Head of the Department of Oncology and Medical Physics at Haukeland University Hospital, Professor of Medicine (Oncology) at the University of Bergen and Director Clinical R&D, Oncology for Pharmacia & Upjohn in Milan. He was also employed at Oslo Universitetssykehus Hf Chairman) and Health Faculty at Tromso University (Chairman). Dr. Kvinnsland also serves on the Board of BergenBio.
This person is not in the org chart
This person is not in any offices
APIM Therapeutics
APIM Therapeutics is developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen).